Results 221 to 230 of about 176,259 (332)
CLDN18.2 CAR‐T cell‐derived small extracellular vesicles (CAR‐sEVs) display potent cytotoxicity and prolong survival in preclinical pancreatic cancer models. They contain functional CAR proteins and granzyme B, exhibit antigen specificity, and effectively target tumor cells while sparing healthy cells.
Yue Qing+7 more
wiley +1 more source
Beta‐glucans have gained significant attention as an immunomodulatory biomaterial with cell‐targeting capabilities. This review comprehensively outlines the design and fabrication methods for producing beta‐glucan particles at both the micro and nanoscale and their applications in immune cell targeting, immunomodulation, and drug delivery ...
Nate Dowdall, Todd Hoare
wiley +1 more source
Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms. [PDF]
Angerilli V+16 more
europepmc +1 more source
Mesenteric venous collateral vessels mimicking cystic pancreatic neoplasm [PDF]
Baskaran Sundaram+5 more
openalex +1 more source
Multimaterial volumetric and embedded extrusion bioprinting of complex cell‐laden architectures is enabled by unravelling the interplay between molecular weight and degree of functionalization in gelatin‐based bioresins. Tomographic light‐responsive support baths for suspended printing can be easily generated from single component materials.
Davide Ribezzi+11 more
wiley +1 more source
This work explores the MOF landscape to select a single, optimal candidate for successfully delivering cancer drugs (gemcitabine, paclitaxel, SN‐38) into tough pancreatic tumors. Machine learning and simulations guide this search, demonstrating colloidal stability, excellent biocompatibility, cellular uptake, and sustained release.
Francesca Melle+9 more
wiley +1 more source
Pancreatic intraductal papillary mucinous neoplasm with concomitant heterotopic pancreatic cystic neoplasia of the stomach: a case report and review of the literature [PDF]
Dimitrios Tsapralis+6 more
openalex +1 more source
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
CART cell therapy has proven effective for blood cancers but struggles with solid tumors due to diverse antigens and complex environments. Recent efforts focus on improving CAR design and validation platforms. Advances in protein engineering, machine learning, and organoid systems aim to enhance CAR‐T therapy against solid tumors.
Danqing Zhu+4 more
wiley +1 more source